Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program

Purpose:Differentiated thyroid cancer (DTC) accounts for approximately 95% of thyroid carcinomas. In the metastatic RAI-refractory disease, chemotherapy has very limited efficacy and is associated with substantial toxicity. With increasing knowledge of the molecular pathogenesis of DTC, novel target...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Cancer
Главные авторы: Balmelli, Catharina, Railic, Nikola, Siano, Marco, Feuerlein, Kristin, Cathomas, Richard, Cristina, Valerie, Güthner, Christiane, Zimmermann, Stefan, Weidner, Sabine, Pless, Miklos, Stenner, Frank, Rothschild, Sacha I.
Формат: Artigo
Язык:Inglês
Опубликовано: Ivyspring International Publisher 2018
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5771331/
https://ncbi.nlm.nih.gov/pubmed/29344270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.22318
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы